ATE309806T1 - Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen - Google Patents

Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen

Info

Publication number: ATE309806T1
Authority: AT; Austria
Prior art keywords: vitamin; systemic inflammatory; containing selenium; treatment; copper
Prior art date: 1998-08-31

Application number

AT99940254T

Other languages

English (en)

Inventor

Xavier Forceville

Dominique Vitoux

Original Assignee

Xavier Forceville

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-31

Filing date

1999-08-30

Publication date

2005-12-15

1999-08-30 Application filed by Xavier Forceville filed Critical Xavier Forceville

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE309806T1 publication Critical patent/ATE309806T1/de

Links

BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title abstract 3
239000011669 selenium Substances 0.000 title abstract 3
229910052711 selenium Inorganic materials 0.000 title abstract 3
230000002757 inflammatory effect Effects 0.000 title abstract 2
208000011580 syndromic disease Diseases 0.000 title 1
230000009885 systemic effect Effects 0.000 title 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 2
239000011230 binding agent Substances 0.000 abstract 2
229910052802 copper Inorganic materials 0.000 abstract 2
239000010949 copper Substances 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 2
102000004127 Cytokines Human genes 0.000 abstract 1
108090000695 Cytokines Proteins 0.000 abstract 1
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
108010024636 Glutathione Proteins 0.000 abstract 1
206010061218 Inflammation Diseases 0.000 abstract 1
206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 abstract 1
229930003268 Vitamin C Natural products 0.000 abstract 1
229930003427 Vitamin E Natural products 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
230000001580 bacterial effect Effects 0.000 abstract 1
230000005713 exacerbation Effects 0.000 abstract 1
230000002538 fungal effect Effects 0.000 abstract 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
229960003180 glutathione Drugs 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
230000002458 infectious effect Effects 0.000 abstract 1
230000004054 inflammatory process Effects 0.000 abstract 1
229910052742 iron Inorganic materials 0.000 abstract 1
230000036542 oxidative stress Effects 0.000 abstract 1
230000003071 parasitic effect Effects 0.000 abstract 1
230000007170 pathology Effects 0.000 abstract 1
239000002243 precursor Substances 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1
230000002195 synergetic effect Effects 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1
235000019154 vitamin C Nutrition 0.000 abstract 1
239000011718 vitamin C Substances 0.000 abstract 1
235000019165 vitamin E Nutrition 0.000 abstract 1
229940046009 vitamin E Drugs 0.000 abstract 1
239000011709 vitamin E Substances 0.000 abstract 1
239000011701 zinc Substances 0.000 abstract 1
229910052725 zinc Inorganic materials 0.000 abstract 1
235000016804 zinc Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/06—Chelate

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Inorganic Chemistry (AREA)
Epidemiology (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99940254T 1998-08-31 1999-08-30 Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen ATE309806T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9810889A FR2782642B1 (fr)	1998-08-31	1998-08-31	Utilisation du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs), et composition pour la mise en oeuvre du traitement
PCT/FR1999/002066 WO2000012101A2 (fr)	1998-08-31	1999-08-30	Composition contenant du selenium pour le traitement de patients atteints d'un syndrome de reponse inflammatoire systemique (sirs)

Publications (1)

Publication Number	Publication Date
ATE309806T1 true ATE309806T1 (de)	2005-12-15

Family

ID=9530002

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99940254T ATE309806T1 (de)	1998-08-31	1999-08-30	Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen

Country Status (12)

Country	Link
US (2)	US6844012B1 (de)
EP (1)	EP1107767B1 (de)
JP (1)	JP4955147B2 (de)
AT (1)	ATE309806T1 (de)
AU (1)	AU760534B2 (de)
BR (1)	BR9913339A (de)
CA (1)	CA2341601C (de)
DE (1)	DE69928410T2 (de)
DK (1)	DK1107767T3 (de)
ES (1)	ES2252963T3 (de)
FR (1)	FR2782642B1 (de)
WO (1)	WO2000012101A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA02011528A (es) *	2000-05-25	2003-04-25	Pharmaton Sa	Metodo para mejorar la proteccion celular.
EP1205471A1 (de) *	2000-10-02	2002-05-15	PharmaSe, Incorporated	Verfahren zur Anwendung von synthetischem L-Se-Methylselenocystein als Nahrungs- und Heilmittel und Verfahren zu seiner Herstellung
WO2002093175A1 (en) *	2001-05-16	2002-11-21	Xavier Forceville	Methods and kits for the in vitro diagnostic or for the monitoring of a disease involving an inflammatory reaction
US7449451B2 (en) *	2001-08-29	2008-11-11	Premier Micronutrient Corporation	Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US6849613B2 (en)	2001-08-29	2005-02-01	Kedar N. Prasad	Multiple antioxidant micronutrients
US20040110691A1 (en) *	2001-11-13	2004-06-10	Stamler Jonathan S.	Thiol reactive agents as a therapeutic modality
AT412703B (de)	2001-12-04	2005-06-27	Vis Vitalis Lizenz & Handels	Verwendung von selenithältigen präparaten zur topischen oder bukkalen anwendung
EP1374892A1 (de) *	2002-06-28	2004-01-02	Braun, Jan Matthias, Dr.	Arzneimittel zur Behandlung von infektiösen Krankheiten infolge Neisseria Meningitidis
DE10321029A1 (de) *	2003-05-10	2004-12-02	Sigrid Heide	Arzneimittel mit Selenit
DE10349115A1 (de) *	2003-10-22	2005-06-16	Biosyn Arzneimittel Gmbh	Kombinationspräparat zur Behandlung der Sepsis
FR2873376B1 (fr) *	2004-07-23	2006-11-24	Tetrahedron Sas	Nouveaux seleno-hydroxyacides et leurs derives, applications en nutrition, cosmetique et pharmacie
FR2883884B1 (fr) *	2005-03-30	2012-11-09	Lallemand Sas	Preparation de levures a proprietes anti-oxydantes ameliorees et leurs applications
US8263137B2 (en) *	2005-08-04	2012-09-11	Vertical Pharmaceuticals, Inc.	Nutritional supplement for women
US7998500B2 (en) *	2005-08-04	2011-08-16	Vertical Pharmaceuticals, Inc.	Nutritional supplement for women
US7901710B2 (en) *	2005-08-04	2011-03-08	Vertical Pharmaceuticals, Inc.	Nutritional supplement for use under physiologically stressful conditions
US8202546B2 (en)	2005-08-04	2012-06-19	Vertical Pharmaceuticals, Inc.	Nutritional supplement for use under physiologically stressful conditions
US20070082064A1 (en) *	2005-10-12	2007-04-12	Krawitz Paul L	Nutritional or dietary supplement for the treatment of macular degeneration
WO2007089267A1 (en)	2006-02-03	2007-08-09	Jr Chem, Llc	Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) *	2006-02-03	2011-03-01	Jr Chem, Llc	Chemical compositions and methods of making them
US7687650B2 (en)	2006-02-03	2010-03-30	Jr Chem, Llc	Chemical compositions and methods of making them
US7867522B2 (en)	2006-09-28	2011-01-11	Jr Chem, Llc	Method of wound/burn healing using copper-zinc compositions
WO2008082972A2 (en) *	2006-12-28	2008-07-10	Nutrition 21, Inc.	A method of treating and preventing viral infections
US8273791B2 (en)	2008-01-04	2012-09-25	Jr Chem, Llc	Compositions, kits and regimens for the treatment of skin, especially décolletage
US20090208543A1 (en) *	2008-01-22	2009-08-20	Oral Health Clinical Services	Method and apparatus for applying a protective oral care composition
AU2009244790B2 (en) *	2008-05-09	2013-09-12	Duke University	Treatment for diseases relying on discovery that thioredoxin mediates nitric oxide release in cells
US20160184354A1 (en)	2009-01-23	2016-06-30	Jr Chem, Llc	Rosacea treatments and kits for performing them
US20110008271A1 (en) *	2009-07-13	2011-01-13	Jr Chem, Llc	Rosacea treatments using polymetal complexes
US8952057B2 (en)	2011-01-11	2015-02-10	Jr Chem, Llc	Compositions for anorectal use and methods for treating anorectal disorders
AT511159A1 (de)	2011-02-16	2012-09-15	Selo Medical Gmbh	Pharmazeutische zusammensetzungen enthaltend selenit- oder selenathältige verbindungen
US10499682B2 (en)	2014-08-25	2019-12-10	New Age Beverage Corporation	Micronutrient formulation in electronic cigarettes
US10058542B1 (en)	2014-09-12	2018-08-28	Thioredoxin Systems Ab	Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
FR3037798A1 (fr)	2015-06-25	2016-12-30	Serenite-Forceville	Composition comprenant au moins un compose selenie pour le traitement du sepsis et/ou de toute hyper-inflammation generalisee (sirs) ou cellulaire dommageable
US10751315B2 (en) *	2017-08-29	2020-08-25	National Jewish Health	Methods and compositions for treating infection and inflammation with selenocyanate
US12110564B2 (en)	2018-05-07	2024-10-08	Yale University	Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
CN111568921A (zh) *	2020-04-20	2020-08-25	奥格生物技术（六安）有限公司	一种促进冠状病毒患者康复的新型硒制剂配方及其制备方法
US11786548B2 (en)	2020-07-02	2023-10-17	American Regent, Inc.	Trace element compositions, methods of making and use
CN111748533B (zh) *	2020-07-03	2021-04-02	华中农业大学	白蚁SelT基因及其dsRNA结合金龟子绿僵菌在白蚁防治中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5929063A (en) *	1995-03-24	1999-07-27	Children's Hospital Medical Center	Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
IT1290907B1 (it) *	1997-01-31	1998-12-14	Idi Farmaceutici Spa	Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
GB9722361D0 (en) *	1997-10-24	1997-12-17	Pharma Nord Uk Ltd	Pharmaceutical formulation for treating liver disorders

1998
- 1998-08-31 FR FR9810889A patent/FR2782642B1/fr not_active Expired - Fee Related
1999
- 1999-08-30 ES ES99940254T patent/ES2252963T3/es not_active Expired - Lifetime
- 1999-08-30 AU AU54270/99A patent/AU760534B2/en not_active Ceased
- 1999-08-30 BR BR9913339-3A patent/BR9913339A/pt not_active Application Discontinuation
- 1999-08-30 DK DK99940254T patent/DK1107767T3/da active
- 1999-08-30 DE DE69928410T patent/DE69928410T2/de not_active Expired - Lifetime
- 1999-08-30 AT AT99940254T patent/ATE309806T1/de active
- 1999-08-30 JP JP2000567218A patent/JP4955147B2/ja not_active Expired - Fee Related
- 1999-08-30 EP EP99940254A patent/EP1107767B1/de not_active Expired - Lifetime
- 1999-08-30 US US09/763,870 patent/US6844012B1/en not_active Expired - Lifetime
- 1999-08-30 CA CA2341601A patent/CA2341601C/fr not_active Expired - Fee Related
- 1999-08-30 WO PCT/FR1999/002066 patent/WO2000012101A2/fr not_active Ceased
2004
- 2004-12-23 US US11/019,513 patent/US7635491B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP4955147B2 (ja)	2012-06-20
EP1107767A2 (de)	2001-06-20
AU760534B2 (en)	2003-05-15
BR9913339A (pt)	2001-05-15
CA2341601A1 (fr)	2000-03-09
EP1107767B1 (de)	2005-11-16
ES2252963T3 (es)	2006-05-16
AU5427099A (en)	2000-03-21
US20050163862A1 (en)	2005-07-28
WO2000012101A2 (fr)	2000-03-09
DE69928410T2 (de)	2006-08-03
US6844012B1 (en)	2005-01-18
JP2002523463A (ja)	2002-07-30
CA2341601C (fr)	2011-10-25
FR2782642B1 (fr)	2001-12-07
DE69928410D1 (de)	2005-12-22
WO2000012101A3 (fr)	2000-06-15
US7635491B2 (en)	2009-12-22
FR2782642A1 (fr)	2000-03-03
DK1107767T3 (da)	2006-04-03

Legal Events

Date

Code

Title

Description

2006-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1107767

Country of ref document: EP

Publication	Publication Date	Title
DE69928410D1 (de)	2005-12-22	Selenium enthaltende zusammensetzung zur behandlung von systemischen entzündungssyndromen
TR200001203T2 (tr)	2000-08-21	Yeni birleşik maddeler
DE69905368D1 (en)	2003-03-20	Oxydiertes thymosin beta 4
MXPA04000222A (es)	2004-05-04	Combinaciones para el tratamiento de desordenes inflamatorios.
IL87886A (en)	1993-06-10	Pharmaceutical composition having antiprogestational and anti-estrogenic activities for gynecological use
MY113079A (en)	2001-11-30	Estrogen agonists as remedies for cardiovascular diseases
ATE236870T1 (de)	2003-04-15	Substituierte 2-phenyl-1-(3,4-dihydroxy-5- nitrophenyl)-1-ethanone, deren verwendung zur behandlung von erkrankungen des zentralen und periphären nervensystems und diese enthaltende pharmazeutische zusammensetzungen
ATE392208T1 (de)	2008-05-15	Zusammensetzungen zur prävention und behandlung von erkältung und grippe-ähnlichen symptomen, die cheliertes zink enthalten
DE69835824D1 (de)	2006-10-19	Antitumorkombination aus 3-amino-1,2,4-benzotriazine 1,4-dioxid/paclitaxel/platin
DE60031016D1 (de)	2006-11-09	Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen
DE69718469D1 (de)	2003-02-20	Verbindungen mit wachtumshormon freisetzenden eigenschaften
DK227090A (da)	1990-09-20	Organisk guldkompleks til topisk anvendelse
DE60320034D1 (de)	2008-05-08	Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
AU1556800A (en)	2000-06-13	Hyperforin as cytostatic agent and hyperforin ointment or cream as application form
ATE500269T1 (de)	2011-03-15	Verbindungen mit wachstumshormon-freisetzenden eigenschaften
ATE224195T1 (de)	2002-10-15	Glucocorticoide zur behandlung von glomerulonephitis
ATE283059T1 (de)	2004-12-15	Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit
TR200200987T2 (tr)	2002-09-23	Kanser tedavisine yönelik,ornatılmış pirroller
DE69426986D1 (de)	2001-05-03	Behandlung von laminitis
ATE232541T1 (de)	2003-02-15	Gallensauersälze mit physiologisch aktiven metalle und ihre verwendung zur therapeutischen behandlung
MD980129A (en)	2000-04-30	Antiherpetic remedy
NO20012169L (no)	2001-05-02	Forbindelser med veksthormonfrigjörende egenskaper
IL129267A0 (en)	2000-02-17	Treatment of urinary incontinence and compositions for use therein
TR200101729T2 (tr)	2001-10-22	IL-5 engelleyici 6-azaurasil türevleri
ATE205398T1 (de)	2001-09-15	Insulinähnlicher wachstumfaktor ii als antitumormittel